Markers of cartilage and synovial metabolism in joint fluid and serum of patients with chondromalacia of the patella

Osteoarthritis and Cartilage

Volumn 6, Issue 2, 1998, Pages 115-124

  Väätäinen, Urho ^a   Lohmander, L Stefan ^b   Thonar, Eugene ^c   Hongisto, Tero ^d   Ågren, Ulla ^d   Rönkkö, Seppo ^a   Jaroma, Heikki ^a   Kosma, Veli Matti ^d   Tammi, Markku ^d   Kiviranta, Ilkka ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d Box 1777 ^*

Author keywords

Chondromalacia; Joint fluid; Knee; Marker; Osteoarthritis

Indexed keywords

COLLAGENASE; HYALURONIC ACID; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; KERATAN SULFATE; MARKER; METALLOPROTEINASE; PHOSPHOLIPASE; STROMELYSIN; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; ARTICULAR CARTILAGE; CHONDROMALACIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; JOINT DEGENERATION; JOINT INJURY; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PATELLA; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS; RHEUMATOID ARTHRITIS; SERUM; SYNOVIAL FLUID; SYNOVITIS; SYNOVIUM;

EID: 0032031098     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1053/joca.1997.0101     Document Type: Article

References (59)

1. 1. Laurin CA, Dussault R, Levesque HP. The tangential X-ray investigation of the patellofemoral joint: X-Ray technique, diagnostic criteria and their interpretation. Clin Orthop 1979;144:16-26.
2. 2. Nguyen Q, Murphy G, Roughley PJ, Mort JS. Proteoglycan aggregate degradation by a cartilage metalloproteinase. Evidence for the involvement of stromelysin in the generation of link protein heterogeneity in situ. Biochem J 1989;259:61-7.
3. 3. Dean DD, Martel-Pelletier J, Pelletier J-P, Howell DS, Woessner JF Jr. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 1989;84:678-85.
4. 4. Pelletier J-P, Mineau F, Faure M-P, Martel-Pelletier J. Imbalance between the mechanisms of activation and inhibition of metalloproteinases in early lesions of experimental osteoarthritis. Arthritis Rheum 1990;33:1466-76.
5. 5. Lohmander LS, Hoerrner LA, Lark MW. Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum 1993;2:181-9.
6. 6. McCachren SS, Haynes BF, Niedel JE. Localization of collagenase mRNA in rheumatoid arthritis synovium by in situ hybridization histochemistry. J Clin Immunol 1990;10:19-27.
7. 7. Lefebvre V, Peeters-Joris C, Vaes G. Modulation by interleukin 1 and tumour necrosis factor of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes. Biochim Biophys Acta 1990;1052:366-78.
8. 8. MacNaul K, Chartrain N, Lark M, Tocci MJ, Hutchinson NI. Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. J Biol Chem 1990;28:17238-45.
9. 9. Wood DD, Ihrie EJ, Hamerman D. Release of interleukin-1 from human synovial tissue in vitro. Arthritis Rheum 1985;28:853-62.
10. 10. Shinmei M, Masuda K, Kikuchi T, Shimomura Y. The role of cytokines in chondrocyte mediated cartilage degradation. J Rheumatol Suppl 1989;18:32-4.
11. 11. Dayer JM, de Rochemonteix B, Burrus B, Demczuk S, Dinarello CA. Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest 1986;77:645-8.
12. 12. Martel-Pelletier J, Zafarullah M, Kodama S, Pelletier JP. In vitro effects of interleukin 1 on synthesis of metalloproteases, TIMP-1, plasminogen activators and inhibitors in human articular cartilage. J Rheum Suppl 1991;27:80-4.
13. 13. Okada Y, Shinmei M, Tanaka O, Naka K, Kimura A, Nakanishi I, et al. Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest 1992;6:680-90.
14. 14. Sipe DJ, Martel-Pelletier J, Otterness IG, Pelletier J-P. Cytokine reduction in the treatment of joint conditions. Mediators Inflammation 1994;3:243-56.
15. 15. Nietfeld JJ, Wilbrink B, Helle M, van-Roy JL, den-Otter W, Swaak AJ et al. Interleukin-1 induced interleukin-6 is required for the inhibition of proteoglycan synthesis by interleukin-1 in human articular cartilage. Arthritis Rheum 1990;11:1695-701.
16. 16. Kandel RA, Petelycky M, Dinarello CA, Minden M, Pritzker KPH, Cruz TF. Comparison of the effect of interleukin 6 and interleukin 1 on collagenase and proteoglycan production by chondrocytes. J Rheumatol 1990;17:953-7.
17. 17. Ito A, Itoh Y, Sasaguri Y, Morimatsu M, Mori Y. Effects of interleukin-6 on the metabolism of connective tissue components in rheumatoid synovial fibroblasts. Arthritis Rheum 1992;10:1197-201.
18. 18. Lotz M, Guerne PA. Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem 1991;266:2017-20.
19. 19. Lyons GB, Pratta MA, Galbraith W, Davis GL, Arner EC. Interleukin-1 differentially modulates chondrocyte expression of cyclooxygenase-2 and phospholipase A2. Exp Cell Res 1993;206:58-62.
20. 20. Vadas P, Stefanski E, Pruzanski W. Characterization of extracellular phospholipase A2 in rheumatoid synovial fluid. Life Sci 1985;36:579-87.
21. 21. Pruzanski W, Vadas P. Phospholipase A2 - a mediator between proximal and distal effectors on inflammation. Immunol Today 1991;12:143-6.
22. 22. Nevalainen TJ, Marki F, Kortesuo PT, Grutter MG, Di-Marco S, Schmitz A. Synovial type (group II) phospholipase A2 in cartilage. J Rheumatol 1993;2:325-30.
23. 23. Kortekangas P, Aro HT, Nevalainen TJ. Group II phospholipase A2 in synovial fluid and serum in acute arthritis. Scand J Rheumatol 1994;2:68-72.
24. 24. Ogston AG, Stainer JE. The physiological function of hyaluronic acid in synovial fluid: viscous, elastic and lubricant properties. J Physiol 1953;119:244-52.
25. 25. Goa KL, Benfield P. Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing. Drugs 1994;47:536-66.
26. 26. Haubeck H-D, Kock R, Fischer D-C, Van De Leur E, Hoffmeister K, Greiling H. Transforming growth factor β. 1, a major stimulator of hyaluronan synthesis in human synovial lining cells. Arthritis Rheum 1995;38:669-77.
27. 27. Castor CW, Prince RK, Hazelton MJ. Hyaluronic acid in human synovial fluid effusions: a sensitive indicator of altered connective tissue cell function during inflammation. Arthritis Rheum 1966;9:783-94.
28. 28. Walakovits LA, Moore VL, Bhardwaj N, Gallick GS, Lark MW. Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury. Arthritis Rheum 1992;35:35-42.
29. 29. Lohmander LS, Hoerrner LA, Dahlberg L, Roos H, Björnsson S, Lark MW. Stromelysin, tissue inhibitor of metalloproteinases and proteoglycan fragments in human knee joint fluid after injury. J Rheumatol 1993;20:1362-8.
30. 30. Levick JP. Determinants of volume turnover and material concentration. In Kuettner KE, Schleyerbach R, Peyron JG, Hascall VC, Eds. Articular cartilage and osteoarthritis. New York, Raven Press 1992:529-41.
31. 31. Thonar EJ, Glant T. Serum keratan sulfate - a marker of predisposition to polyarticular osteoarthritis. Clin Biochem 1992;3:175-80.
32. 32. Ahlbäck S. Osteoarthrosis of the knee: a radiographic investigation. Acta Radiol Suppl 1968;277:7-72.
33. 33. Outerbridge RE. The etiology of chondromalacia patellae. J Bone Joint Surg (Br) 1961;4:752-7.
34. 34. Rönkkö S, Lahtinen R, Vanha-Perttula T. Phospholipase A2 in the reproductive system of the bull. Int J Biochem 1991;23:595-603.
35. 35. Saxne T, Heinegård D, Wollheim FA. Therapeutic effects on cartilage metabolism in arthritis as measured by release of proteoglycan structures into the synovial fluid. Ann Rheum Dis 1986;45:491-7.
36. 36. Saxne T, Heinegård D. Synovial fluid analysis of two groups of proteoglycan epitopes distinguishes early and late cartilage lesions. Arthritis Rheum 1992;35:385-90.
37. 37. Thonar EJ-MA, Lenz ME, Klintworth GK et al. Quantification of keratan sulfate in blood as a marker of cartilage catabolism. Arthritis Rheum 1985;28:1367-76.
38. 38. Thonar EJ-MA, Schnitzer TJ, Kuettner KE. Quantification of keratan sulfate in blood as a marker of cartilage catabolism. J Rheumatol Suppl 1987;14:23-4.
39. 39. Wang C, Tammi M, Tammi R. Distribution of HA and its CD44 receptor in the epithelia of human skin appendages. Histochemistry 1992;98:105-12.
40. 40. Kongtawelert P, Ghosh P. A method for the quantitation of hyaluronan (hyaluronic acid) in biological fluids using a labelled avidin-biotin technique. Anal Biochem 1990;185:313-8.
41. 41. Cooksley S, Hipkiss JB, Tickle SP, Holmes-levers E, Docherty AJP, Murphy G et al. Immunoassays for the detection of human collagenase; stromelysin; tissue inhibitor of metalloproteinases (TIMP-1) and enzyme-inhibitor complexes. Matrix 1990;10:285-91.
42. 42. Lohmander LS, Dahlberg L, Ryd L, Heinegård D. Increased levels of proteoglycan fragments in knee joint fluid after injury. Arthritis Rheum 1989;32:1434-42.
43. 43. Simkin PA, Bassett JE. Cartilage matrix molecules in serum and synovial fluid. Curr Opin Rheumatol 1995;7:346-51.
44. 44. Väätäinen U, Häkkinen T, Kiviranta I, Jaroma H, Inkinen R, Tammi M. Proteoglycan depletion and size reduction in the lesions of early grade chondromalacia of the patella. Ann Rheum Dis 1995;54:831-5.
45. 45. Hughes C, Murphy G, Hardingham TE. Metalloproteinase digestion of cartilage proteoglycan. Biochem J 1991;279:733-9.
46. 46. Fosang AJ, Neame PJ, Hardingham TE, Murphy G, Hamilton JA. Cleavage of cartilage proteoglycan between G1 and G2 domains by stromelysins. J Biol Chem 1991;24:15579-82.
47. 47. Woessner JF Jr, Selzer MG. Two latent metalloproteases of human articular cartilage that digest proteoglycan. J Biol Chem 1984;259:3633-8.
48. 48. Lohmander LS, Neame P, Sandy JD. The structure of aggrecan fragments in human synovial fluid: Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury and osteoarthritis. Arthritis Rheum 1993;36:1214-22.
49. 49. Coulombe B, Ponton A, Kerbel RS, Skup D. Structure and function of murine TIMP gene. Matrix Suppl 1992;1:269-74.
50. 50. Mort JS, Dodge GR, Roughley P, Liu J, Finch SJ, Dipasquale G et al. Direct evidence for active metalloproteinases mediating matrix degradation in interleukin 1-stimulated human articular cartilage. Matrix 1993;13:95-102.
51. 51. Vignon E, Mathieu P, Louisot P, Vilamitjana J, Harmand MF, Richard M. Phospholipase A2 activity in human osteoarthritic cartilage. J Rheumatol Suppl 1989;18:35-8.
52. 52. Manicourt DH, Lenz ME, Thonar EJ. Levels of serum keratan sulfate rise rapidly and remain elevated following anterior cruciate ligament transection in the dog. J Rheumatol 1991;12:1872-6.
53. 53. Ratcliffe A, Billingham ME, Saed-Nejad F, Muir H, Hardingham TE. Increased release of matrix components from articular cartilage in experimental canine osteoarthritis. J Orthop Res 1992;10:350-8.
54. 54. Ratcliffe A, Beauvais, Saed-Nejad F, Shurety W, Caterson. Synovial fluid analyses detect and differentiate proteoglycan metabolism in canine experimental models of osteoarthritis and disuse atrophy. In van den Berg WB, van der Kraan PM, van Lent PLEM, Eds. Joint Destruction in Arthritis and Osteoarthritis, Basel, Birkhäuser Verlag 1993:63-7.
55. 55. Thonar EJ, Masuda K, Lenz ME, Hauselmann HJ, Kuettner KE, Manicourt DH. Serum markers of systemic disease processes in osteoarthritis. J Rheumatol Suppl 1995;43:68-70.
56. 56. Schiller S, Mathews MB, Cifonelli JA, Dorfman A. The metabolism of mucopolysaccharides in animals. III Further studies on skin utilizing C14-glucose, C14-acetate and S35-sodium sulfate. J Biol Chem 1956;218:139-45.
57. 57. Fraser JRE, Laurent TC. Turnover and metabolism of hyaluronan. In Evered D, Whelan J, Eds. The biology of hyaluronan, CIBA Foundation Symposium 143 New York, John Wiley & Sons 1989:41-53.
58. 58. Laurent UBG, Reed R. Turnover of hyaluronan in the tissues. Adv Drug Del Rev 1991;7:237-56.
59. 59. Fraser JR, Kimpton WG, Pierscionek BK, Cahill RN. The kinetics of hyaluronan in normal and acutely inflamed synovial joints: observations with experimental arthritis in sheep. Semin Arthritis Rheum 6 Suppl 1993;1:9-17.